GRAIL, Inc.

GRAL ·Healthcare, Medical Care Facilities, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023
Revenue $147.2M $125.6M $93.1M
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $195.8M $322.4M $338.7M
SG&A Expense $159.1M $213.9M $200.3M
Operating Income $-562.2M $-2.19B $-1.52B
Operating Margin -382.0% -1,743.0% -1,627.6%
Interest Expense
Pretax Income $-534.5M $-2.16B $-1.51B
Income Tax Expense $-126.2M $-135.4M $-42.0M
Net Income $-408.4M $-2.03B $-1.47B
Net Margin -277.5% -1,613.9% -1,574.2%
EPS (Basic) $-11.11 $-63.54 $-47.21
EPS (Diluted) $-11.11 $-63.54 $-47.21
Shares Outstanding (Basic) 41.0M 36.8M 31.9M 31.0M
Shares Outstanding (Diluted) 41.0M 36.8M 31.9M 31.0M
Dividends Per Share